Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents

Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents

BackgroundManagement of coronary artery disease (CAD) is unique and challenging in cancer patients. However, little is known about the outcomes of using BMS or DES in these patients. This study aimed to compare the outcomes of percutaneous coronary intervention (PCI) in cancer patients who were trea...

Full description

Bibliographic Details
Main Authors:	Talha Ahmed, Homam Moussa Pacha, Antoine Addoumieh, Efstratios Koutroumpakis, Juhee Song, Konstantinos Charitakis, Konstantinos Dean Boudoulas, Mehmet Cilingiroglu, Konstantinos Marmagkiolis, Cindy Grines, Cezar A. Iliescu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	percutaneous coronary intervention bare metal stents drug-eluting stents cardio-oncology revascularization
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2022.901431/full

Similar Items

Natural history of coronary stents: 14 year follow-up of drug eluting stents versus bare metal stents
by: Rohit Sunil Walse, et al.
Published: (2023-11-01)

Comparison of drug-eluting and bare-metal stents in patients with saphenous vein graft stenosis
by: Ahmed Zayed, et al.
Published: (2020-01-01)

Direct comparison of coronary bare metal vs. drug-eluting stents: same platform, different mechanics?
by: Wolfram Schmidt, et al.
Published: (2018-01-01)

Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics
by: Kakhaber Etsadashvili, et al.
Published: (2011-06-01)

Comparison between a Bare–Metal Stents and Drug Eluting Stents in patients undergoing Percutaneous Coronary Intervention.
by: Khaled Alsayed
Published: (2020-10-01)

Effect of a Drug-Eluting Stent vs. Bare Metal Stent for the Treatment of Symptomatic Intracranial and Vertebral Artery Stenosis
by: Jiang-Hua Si, et al.
Published: (2022-07-01)

POR QUÉ USAR PREFERENTEMENTE STENTS NO FARMACOACTIVOS / Why it is preferable to use non-drug-eluting stents
by: Rosa Lázaro García, et al.
Published: (2013-10-01)

Very Late Pathological Responses to Cobalt–Chromium Everolimus‐Eluting, Stainless Steel Sirolimus‐Eluting, and Cobalt–Chromium Bare Metal Stents in Humans
by: Hiroyoshi Mori, et al.
Published: (2017-11-01)

One-Year clinical outcomes of drug-eluting stents versus bare-metal stents in large coronary arteries
by: Roopesh Singhal, et al.
Published: (2020-01-01)

The relevance of bare-metal stent in the therapy of coronary artery disease in 2020
by: Saumitra Ray
Published: (2021-01-01)

Caracterización de la restenosis de stents coronarios convencionales y liberadores de medicamentos en pacientes incluidos en el registro DRug Eluting STent (DREST) Characterization of conventional coronary stents restenosis and drug eluting stents in patients included in the Drug Eluting Stent Registry (DREST)
by: Jorge A Arroyave C, et al.
Published: (2012-06-01)

Intravascular imaging analysis of a drug-eluting balloon followed by a bare metal stent compared to a drug-eluting stent for treatment of de novo lesions
by: Wonsuk Choi, et al.
Published: (2019-07-01)

Drug-eluting coronary stents in clinical practice: lessons from the «BAsel Stent Kosten-Effektivitäts Trials» (BASKET)
by: Swiss Medical Weekly
Published: (2011-08-01)

Comparison of the Efficacy of Drug-eluting Stents Versus Bare-metal Stents for the Treatment of Left Main Coronary Artery Disease
by: Xiao-Zeng Wang, et al.
Published: (2015-01-01)

Drug-eluting versus bare-metal stents in primary PCI. Analysis of an 8-year registry
by: Alfredo Redondo Diéguez, et al.
Published: (2019-02-01)

Frequency of In-Stent Restenosis among Different 2nd/3rd Drug Eluting Stents in Patients Presenting with ACS/Angina at Trtiary Cradiac Care Centre
by: Shakir Ghaffar, et al.
Published: (2022-11-01)

Long‐Term Results After Drug‐Eluting Versus Bare‐Metal Stent Implantation in Saphenous Vein Grafts: Randomized Controlled Trial
by: Gregor Fahrni, et al.
Published: (2020-10-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01)

Early coronary stent thrombosis after bare metal stent implantation
by: Laxman Dubey, et al.
Published: (2014-01-01)

Modern Stents: Where Are We Going?
by: Ofer Kobo, et al.
Published: (2020-04-01)

A tale of two in stent restenosis in same patient: Surprising findings from optical coherence tomography
by: Akshyaya Pradhan, et al.
Published: (2023-11-01)

Drug-eluting stents: long-term safety
by: Yu A Karpov, et al.
Published: (2009-05-01)

Improved vascular healing after the successful treatment of very late sirolimus-eluting stent thrombosis with a bare metal stent implantation – A serial optical coherence tomography study
by: Konstantina P. Bouki, MD, et al.
Published: (2016-03-01)

Cost-effectiveness of Drug-eluting Stents in Patients With Stable Coronary Artery Disease
by: Chi-Sheng Hung, et al.
Published: (2011-02-01)

Ureteral stent technology: Drug-eluting stents and stent coatings
by: Luo Yang, et al.
Published: (2015-10-01)

Management of pulmonary artery stent fracture by a stent-in-stent technique
by: Kewal Kanabar, et al.
Published: (2019-01-01)

Comparison of 7-Year, Real-World Clinical Outcomes between Drug-Coated Balloon Angioplasty versus Drug-Eluting Stent Implantation in Patients with Drug-Eluting Stent In-Stent Restenosis
by: Minsu Kim, et al.
Published: (2023-06-01)

INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial
by: Burzotta Francesco, et al.
Published: (2012-05-01)

Late thrombosis of coronary bare-metal stent: Case report
by: Apostolović Svetlana, et al.
Published: (2006-01-01)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
by: Iraj Jafaripour, et al.
Published: (2023-05-01)

Very late stent thrombosis of Sirolimus-eluting stent 59 months after implantation: A first report from the Middle-East and review of literature
by: Prashanth Panduranga, et al.
Published: (2011-01-01)

Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?
by: Flavius-Alexandru Gherasie, et al.
Published: (2023-04-01)

Risk of Heart Failure in Patients with ST-Elevation Myocardial Infarction Receiving Drug-Eluting Stent Implantation and Undefined Duration of Antiplatelets
by: Li-Nien Chien, et al.
Published: (2022-02-01)

Long-Term Outcomes of Contemporary Percutaneous Coronary Intervention with the Xience Drug-Eluting Stent: Results from a Multicentre Australian Registry
by: David S. Eccleston, et al.
Published: (2022-12-01)

Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIOSCIENCE Trial
by: Rainer Zbinden, et al.
Published: (2016-03-01)

Gene Delivery from Stents for Prevention of In Stent Restenosis
by: Ilia Fishbein, et al.
Published: (2016-12-01)

Ten-year survival of patients undergoing coronary angioplasty with first-generation sirolimus-eluting stents and bare-metal stents
by: Nelson Vale, et al.
Published: (2020-11-01)

Very late stent thrombosis of bare-metal coronary stent nine years after primary percutaneous coronary intervention
by: Đurić Predrag, et al.
Published: (2016-01-01)

The effects of dextromethorphan on the outcome of percutaneous coronary intervention with bare-metal stent implantation
by: Wen-Cheng Liu, et al.
Published: (2018-01-01)

Stent thrombosis: Prevention and management
by: Rajendra Kumar Jain, et al.
Published: (2014-01-01)